* Announces cancellation of licensing agreement with Janssen Biotech, Inc. due to strategy reason
* Says all the rights of development and sales from Janssen Biotech, Inc. will be returned
* Says effective on Aug. 23
* Says all the rights of development and sales from Janssen Biotech, Inc. will be returned
* Says effective on Aug. 23